226398-62-5 Usage
General Description
4-(4-Bromo-benzenesulfonyl)-piperidine-1-carboxylic acid tert-butyl ester is a chemical compound with the molecular formula C18H24BrNO4S. It is a piperidine derivative with a tert-butyl ester group attached to the carboxylic acid functional group. The compound also contains a bromo-benzenesulfonyl group, which is a strong electron-withdrawing group. This chemical is commonly used in organic synthesis and medicinal chemistry as a building block for the synthesis of various organic compounds. It is important to handle this chemical with proper care and in accordance with safety regulations due to its potentially hazardous nature.
Check Digit Verification of cas no
The CAS Registry Mumber 226398-62-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,6,3,9 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 226398-62:
(8*2)+(7*2)+(6*6)+(5*3)+(4*9)+(3*8)+(2*6)+(1*2)=155
155 % 10 = 5
So 226398-62-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H22BrNO4S/c1-16(2,3)22-15(19)18-10-8-14(9-11-18)23(20,21)13-6-4-12(17)5-7-13/h4-7,14H,8-11H2,1-3H3
226398-62-5Relevant articles and documents
Synthesis and Characterization of N-(4-(Piperidin-4-ylsulfonyl) phenyl)5-vinylpyrimidin-2-amine
Dong, Jingjing,Feng, Baicheng,Jin, Yan,Lu, Jianqiang,Wang, Tielin
, p. 255 - 258 (2021/08/05)
Target product N-(4-(piperidin-4-ylsulfonyl)phenyl)5-vinylpyrimidin-2- amine (13) was synthesized using 6-oxopyran-3-carbaldehyde (M1) and 4-hydroxypiperidine (M2) as starting materials by a series of nucleophilic substitution and oxidation. Different aci
UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF
-
Paragraph 0139, (2016/02/18)
Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL.
AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES
-
Page/Page column 153; 165, (2013/09/12)
The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.